Total Funding
50
54
Total FundingPost-IPO Equity raised
Growth Score
-23 pts
Heat Score
-24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
192082
Devonian is a late stage botanical pharmaceutical corporation
Luc Gregoire: Executive Vice-President of StrategyPast Role: Devonian Health Group, President and CEO- André Boulet: CEOPast Role: Purgenesis, President & COO
Altius Healthcare
About the Company
Devonian is a late stage botanical pharmaceutical corporation with novel therapeutic approaches targeting worldwide unmet medical needs. Devonian’s core strategy is to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. This strategy is supported by FDA set of regulatory
guidelines, favouring a more efficient drug development pathway for prescription botanical drug products.
